Fred Alger Management LLC Has $11.05 Million Stake in Core Laboratories Inc. $CLB

Key Points

• Fred Alger Management LLC increased its holdings in Core Laboratories Inc. by 32.4%, now owning approximately 1.57% of the company, worth $11,045,000.
• Core Laboratories recently reported an EPS of $0.19, exceeding the consensus estimate, while revenue showed a slight decline of 0.3% year-over-year.
• The company announced a quarterly dividend of $0.01, representing an annualized dividend of $0.04 and a yield of 0.3%.

Fred Alger Management LLC increased its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 32.4% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 736,853 shares of the oil and gas company's stock after purchasing an additional 180,344 shares during the period. Fred Alger Management LLC owned about 1.57% of Core Laboratories worth $11,045,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Core Laboratories by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company's stock worth $418,000 after purchasing an additional 1,170 shares during the period. Ariel Investments LLC boosted its stake in Core Laboratories by 7.4% in the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company's stock worth $155,027,000 after purchasing an additional 709,455 shares during the period. Trexquant Investment LP lifted its stake in shares of Core Laboratories by 24.4% in the 1st quarter. Trexquant Investment LP now owns 128,037 shares of the oil and gas company's stock valued at $1,919,000 after purchasing an additional 25,086 shares during the last quarter. Hotchkis & Wiley Capital Management LLC acquired a new position in Core Laboratories during the 1st quarter worth $6,008,000. Finally, AlphaQuest LLC lifted its position in Core Laboratories by 265,800.0% during the 1st quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company's stock worth $40,000 after acquiring an additional 2,658 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company's stock.

Core Laboratories Trading Down 2.2%

Shares of NYSE CLB traded down $0.28 during midday trading on Friday, reaching $12.39. 369,430 shares of the stock were exchanged, compared to its average volume of 483,995. The business has a 50-day simple moving average of $11.50 and a two-hundred day simple moving average of $12.23. The company has a market capitalization of $580.97 million, a price-to-earnings ratio of 19.98, a P/E/G ratio of 3.74 and a beta of 1.46. Core Laboratories Inc. has a 12 month low of $9.72 and a 12 month high of $21.83. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. The company had revenue of $130.16 million for the quarter, compared to analysts' expectations of $129.19 million. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The business's quarterly revenue was down .3% compared to the same quarter last year. During the same period last year, the firm posted $0.22 earnings per share. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. As a group, equities research analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 25th. Stockholders of record on Monday, August 4th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, August 4th. Core Laboratories's dividend payout ratio (DPR) is currently 6.45%.

Analyst Ratings Changes

CLB has been the subject of a number of research analyst reports. Wall Street Zen raised shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Saturday, July 26th. Zacks Research raised shares of Core Laboratories from a "strong sell" rating to a "hold" rating in a research note on Friday, August 15th. Finally, Stifel Nicolaus lowered their target price on Core Laboratories from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $12.50.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.